A Prospective Study of Olanzapine and Aprepitant for CINV in Cisplatin-HAIC for Hepatocellular Carcinoma (PROACT). Okuyama S, Ueno M, Oi T, Nishikawa S, et al. Anticancer Res 2026;46:395-405.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Okuyama S, Ueno M, Oi T, Nishikawa S, et al. A Prospective Study of Olanzapine and Aprepitant for CINV in Cisplatin-HAIC for Hepatocellular Carcinoma (PROACT). Anticancer Res 2026;46:395-405.
PMID: 41469110